177 related articles for article (PubMed ID: 34326035)
1. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
[TBL] [Abstract][Full Text] [Related]
2. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
4. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
[TBL] [Abstract][Full Text] [Related]
6. Contemporary management of nodal and primary splenic marginal zone lymphoma.
Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
[No Abstract] [Full Text] [Related]
7. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
8. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.
Boveri E; Arcaini L; Merli M; Passamonti F; Rizzi S; Vanelli L; Rumi E; Rattotti S; Lucioni M; Picone C; Castello A; Pascutto C; Magrini U; Lazzarino M; Paulli M
Ann Oncol; 2009 Jan; 20(1):129-36. PubMed ID: 18718888
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
Spina V; Rossi D
Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
[TBL] [Abstract][Full Text] [Related]
11. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
[TBL] [Abstract][Full Text] [Related]
12. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
[TBL] [Abstract][Full Text] [Related]
13. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
14. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
15. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
[TBL] [Abstract][Full Text] [Related]
16. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
17. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and management of marginal zone lymphomas.
Thieblemont C
Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
[TBL] [Abstract][Full Text] [Related]
20. Non-MALT marginal zone lymphoma.
Thieblemont C; Davi F; Noguera ME; Brière J
Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
